MDM2 and MDMX can interact differently with ARF and members of the p53 family

被引:73
|
作者
Wang, XQ
Arooz, T
Siu, WY
Chiu, CHS
Lau, A
Yamashita, K
Poon, RYC
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Life Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
ARF; MDM2; MDMX; p53; p63; p73; tumor suppressor;
D O I
10.1016/S0014-5793(01)02124-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the p53 family of transcription factors have essential roles in tumor suppression and in development, MDM2 is an essential regulator of p53 that can inhibit the transcriptional activity of p53, shuttle p53 out of the nucleus, and target p53 for ubiquitination-mediated degradation. Little is known about the interaction and selectivity of different members of the p53 family (p53, p63, and p73) and the MDM2 family (MDM2 and MDMX). Here we show that the transcriptional activities of p53 and p73, but not that of p63, were inhibited by both MDM2 and MDMX. Consistent with these, we found that MDMX can physically interact with p53 and p73, but not with p63, Moreover, ectopically expressed MDM2 and MDMX could induce alterations in the subcellular localization of p73, but did not affect the subcellular localization of p53 and p63. Finally, we demonstrate that while ARF can interact with MDM2 and inhibit the regulation of p53 by MDM2. no interaction was found between ARF and MDMX. These data reveal that significant differences and selectivity exist between the regulation of different members of the p53 family by MDM2 and MDMX. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [41] P53 escape from P19ARF-trapped MDM2
    Mariani, S
    NATURE MEDICINE, 1999, 5 (05) : 490 - 490
  • [42] Mechanisms of p53 activation by NIAM, nuclear interactor of ARF and MDM2
    Reed, Sara
    Tompkins, Van
    Hagen, Jussara
    Thies, Katie
    Cryderman, Diane
    Wallrath, Lori
    Quelle, Dawn
    CANCER RESEARCH, 2012, 72
  • [43] Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
    Kamijo, T
    Weber, JD
    Zambetti, G
    Zindy, F
    Roussel, MF
    Sherr, CJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8292 - 8297
  • [44] Retinoblastoma and protein expression of P14ARF, MDM2 and P53
    Carvalho, L. M.
    Alarcao, A. M.
    Teixeira, C. L.
    Fonseca, M. C.
    Proenca, R. D.
    HISTOPATHOLOGY, 2010, 57 : 210 - 210
  • [45] P53 escape from P19ARF-trapped MDM2
    Sara Mariani
    Nature Medicine, 1999, 5 : 490 - 490
  • [46] Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
    Moore, L
    Venkatachalam, S
    Vogel, H
    Watt, JC
    Wu, CL
    Steinman, H
    Jones, SN
    Donehower, LA
    ONCOGENE, 2003, 22 (49) : 7831 - 7837
  • [47] MdmX inhibits ARF mediated Mdm2 sumoylation
    Ghosh, M
    Weghorst, K
    Berberich, SJ
    CELL CYCLE, 2005, 4 (04) : 604 - 608
  • [48] Targeted Molecular Therapy for Neuroblastoma: The ARF/MDM2/p53 Axis
    Kim, Eugene
    Shohet, Jason
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (22): : 1527 - 1529
  • [49] ARF function does not require p53 stabilization or Mdm2 relocalization
    Korgaonkar, C
    Zhao, L
    Modestou, M
    Quelle, DE
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) : 196 - 206
  • [50] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678